NASDAQ:FLNA | Free Cash Flow | FILANA THERAPEUTICS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2009-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$8.88M
2025-12-31-$9.75M$501,000.00-$10.25M
2025-03-31-$11.34M$0.00-$11.34M
2024-12-31-$61.27M$57,000.00-$61.32M
2024-03-31-$19.13M$0.00-$19.13M-76.38%
2023-12-31-$22.32M$41,000.00-$22.36M
2023-03-31-$13.26M$357,000.00-$13.61M
2022-12-31-$21.32M-$335,000.00-$21.66M
2022-03-31-$23.53M$425,000.00-$23.96M
2021-12-31-$7.99M$100,000.00-$8.09M
2021-03-31-$2.31M
2020-12-31-$1.18M
2020-03-31-$1.19M
2019-12-31-$589,000.00$0.00-$589,000.00
2019-03-31-$604,000.00$18,000.00-$622,000.00
2018-12-31-$565,000.00
2018-03-31-$1.64M
2017-12-31-$1.44M
2017-03-31-$1.45M
2016-12-31-$3.03M-$1,000.00-$3.03M
2016-03-31-$3.14M
2015-12-31-$3.55M$0.00-$3.55M
2015-03-31-$1.15M$195,000.00-$1.34M
2014-12-31-$2.56M$1,000.00-$2.56M
2014-03-31-$2.72M$79,000.00-$2.8M
2013-12-31-$1.45M
2013-03-31-$1.87M
2012-12-31-$1.85M
2012-03-31-$2.07M
2011-12-31-$809,000.00
2011-03-31$3.27M
2010-12-31-$3.34M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$32.25M$581,000.00-$32.83M
2024-12-31-$116.93M$103,000.00-$117.03M
2023-12-31-$82.03M$414,000.00-$82.44M
2022-12-31-$77.51M$2.71M-$80.23M
2021-12-31-$30.2M$22.21M-$52.41M
2020-12-31-$5.38M
2019-12-31-$2.51M$18,000.00-$2.53M
2018-12-31-$4.77M
2017-12-31-$8.24M
2016-12-31-$12.23M$75,000.00-$12.31M
2015-12-31-$9.05M$195,000.00-$9.25M
2014-12-31-$9.55M$80,000.00-$9.63M
2013-12-31-$6.95M
2012-12-31-$7.17M
2011-12-31-$260,000.00
2010-12-31-$143,000.00
2009-12-31-$14.69M